INTRODUCTION
Studies from a number of laboratories indicate that activation of hormone-sensitive lipase in rat adipose tissue is probably linked to cyclic AMP (1) (2) (3) (4) (5) . Recently, the immediate activating step has been shown to be catalyzed by cyclh,AMP-dependent protein kinase (6, 7) and to involve the transfer of the terminal phosphate of ATP to the lipase (8) . Human adipose tissue differs in several respects from rat adipose tissue. Basal lipolytic Received for publication 8 May 1973 and in revised form 8 October 1973. activity is lower, as is sensitivity to catecholamines (9, 10) . The spectrum of hormone responsiveness is quite different; whereas glucagon, ACTH, and growth hormone are effective stimuli for lipolysis in rat adipose tissue, these hormones have little or no effect on human tissue (11) (12) (13) . Further, human adipocytes appear to have an a-adrenergic receptor mechanism that suppresses lipolysis, while such receptors appear to be lacking in rat adipocytes (14) . While there are thus several properties that differentiate hormonal control of human and rat adipose tissue, there are also important parallels. Lipolysis in both is stimulated by theophylline, a phosphodiesterase inhibitor, and by dibutyryl cyclic AMP (14, 15) . Also, increases in cyclic AMP production have been demonstrated in both species in response to lipolytic hormones (3, 14) . Thus, the qualitative differences noted above may relate exclusively to the pattern of primary receptor sites; the quantitative differences are not, per se, incompatible with the operation of an activation mechanism in human tissue analogous to that in the metabolically more active rat adipocyte.
The present studies describe the partial purification and characterization of hormone-sensitive lipase from human adipose tissue and the demonstration of its activation by cyclic AMP-dependent protein kinase. The properties of the activation system are described, and evidence is presented to support identification of the protein kinase activation mechanism, demonstrated in cell-free preparations, as the physiologic mode of lipase activation in intact human adipose tissue. Preliminary studies have been reported elsewhere (16, 17) .
METHODS
Human subcutaneous adipose tissue was obtained at the time of surgery from three grossly obese subjects undergoing ileo jejunal bypass (L. S., female, age 40; N. S., female, age 28; H. B., male, age 34) and from a 54-yrold woman (M. H.) undergoing mastectomy. The patients had nothing by mouth after 6 p.m. the night before surgery. MI sucrose, 1 mM EDTA, and 10 mM Tris buffer, pH 7.4, at 4°C. The homogenate was subjected to low-speed centrifugation to remove cell debris and the bulk of the fat. The extract was then centrifuged at 100,000g for 30 min. Lipase activity recovered per gram tissue in the 100,000g supernatant fraction was, as expected, much lower than that found in the equivalent fraction from rat adipose tissue-i. e., 50-100 vs. 2,000-4,000 nmol free fatty acid (FFA)1/g per h. The particle-free supernatant fraction was carefully adjusted to pH 5.2 with 0.1 N acetic acid. The precipitate formed was centrifuged down at 1,000g, redissolved in a small volume of buffer containing 20% glycerol, and stored at -20°C. This fraction (designated 5.2 P fraction) was used in all the studies to be described unless otherwise specified. Its specific activity was [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] times that of the 100.000g supernatant fraction, and recoveries ranged from 60 to 100%o. The specific activity of this fraction ranged from 98 to 250 nmol FFA released/ mg of protein per h. In one experiment, the enzyme was further purified by taking up the 5.2 P fraction in a solution containing 0.25 M sucrose, 1 mM EDTA, and 10 mM Tris, pH 7.4, and subjecting it to gel filtration on a 4%o agarose column. Over 53% of the activity emerged in the void peak. The effluent was adjusted to density 1 Unless otherwise stated, the activation of lipase fractions was carried out in a volume of 0.2 ml at 30°C for 10 min at pH 8.0, which was shown to be the pH optimum for the activation step. The system consisted of 50 mM Tris, pH 8.0, 1 mM dithiothreitol, 0.5 mM ethyleneglycolbis (,8-aminoethyl ether) N,N'-tetraacetic acid (EGTA), 5 mM magnesium acetate, and 1.0 mM theophylline, either in the absence (incomplete system) or in the presence (complete system) of 0.5 mM ATP and 0.01 mM cyclic AMP.
The pH-activity curves for both the nonactivated and activated preparations were indistinguishable, showing a rather broad peak between pH 6.8 and 7.4. Therefore, assays of lipase activity were routinely carried out at pH 7.0. Assay of hormone-sensitive lipase was initiated by 'Abbreviations used in this paper: apoLp-Glu, the apoprotein with C-terminal glutamic acid isolated from human very low density lipoprotein; EGTA, ethyleneglycol bis-(#-aminoethyl ether) N,N'-tetraacetic acid; FFA, free fatty acid. (20) . Diolein emulsions were prepared in the same way. Since monoolein did not yield a homogeneous emulsion with 5%o gum arabic, the emulsion was prepared by mixing it with 10 mM taurodeoxycholate, pH 7.0, on a Vortex mixer (Scientific Industries, Inc., Queens Village, N. Y.) as previously described (21) .
Glycerol was determined enzymatically by the method of Wieland (22 Activation as a function of increasing concentrations of ATP from 1 4M to 100 /M at a constant concentration of cyclic AMP (10 AM) is shown in Fig. 1 . Halfmaximal activation was obtained at about 8 uM. Activation as a function of increasing concentrations of cyclic AMP from 0.25-2.5 uM in the presence of a constant concentration of ATP (0.5 mM), is shown in Fig. 2 . Half-maximal activation was obtained at about 3 X 10-M. Activation specifically required ATP and cyclic AMP. Substitution of ITP, GTP, thymidine triphosphate (dTTP), or UTP for ATP or substitution of cyclic GMP, cyclic IMP, or cyclic UMP for cyclic AMP yielded little or no activation (data not shown).
Protein kinase dependency of the activation. To prove that the activation by cyclic AMP and ATP-Mg'+ was due to endogenous protein kinase in the 5.2 P fraction, a specific inhibitor of protein kinase was used (25) . Addition of 7.8I,g of the protein kinase inhibitor to the complete system completely blocked activation (Fig. 3) .
The inhibitory effect was a function of the amount of protein kinase inhibitor added, 50% inhibition being obtained with addition of about 2 Fg (final concentration 10 ALg/ml) (Fig. 3) . This inhibition could be overcome by adding back purified protein kinase from rabbit skeletal muscle as shown in Fig. 4 riod. When the enzyme in the 5.2 P fraction was further purified by gel filtration and by flotation at density 1.15, as described under Methods, activation depended absolutely on the addition of exogenous protein kinase, as shown in Fig. 5 .
The activation of human hormone-sensitive lipase by protein kinase could be an indirect process analogous to the system for activation of phosphorylase. In that case, cyclic AMP-dependent protein kinase activates phosphorylase kinase, which then in turn, activates phosphorylase in a reaction not dependent on cyclic AMP (24). To test for the possible participation of a lipase kinase analogous to phosphorylase kinase, protein kinase inhibitor was added during the course of the activation step. If there were an intermediate enzyme ("lipase kinase"), activation might be expected to continue for some time, even after the protein kinase activity had been completely inhibited. As shown in Fig. 6 , when protein kinase inhibitor was added at 10 min, the activation process was immediately and completely blocked. Addition of an excess amount of protein kinase (80 lAg) overcome this inhibition and allowed activation to continue (Fig. 6) .
Conversion of lipase to the activated form by hormone treatnent of intact tissue. If the activation of hormone-sensitive lipase by cyclic AMP-dependent protein kinase reflects the physiologic process of activation, it would be anticipated that homogenates prepared from tissues previously incubated with lipolytic hormones would contain lipase predominantly in the activated form and therefore show a smaller percentage increase in activity in response to the cyclic AMP system. Pieces of human fat were incubated for 1 h with epinephrine or isoproterenol. At the end of the incubation, the tissues Activation of Hormone Effects of the activation system on hydrolysis of diolein and monoolein. As shown in Table III , the 5.2 P fraction contained much higher levels of activity (about 10-fold higher) against diolein and monoolein than against triolein. However, only the lipase activity against triolein was enhanced by the activation system (110%), whereas the lipase activities against diolein and monoolein were virtually unaltered.
Effects on lipoprotein lipase. It has been proposed that cyclic AMP might be involved in regulation of lipoprotein lipase, the effect being in a direction opposite to that of its effects on hormone-sensitive lipase (27) . In the present studies, the lipoprotein lipase content of the tissue was reduced by incubation of the tissue before homogenization, as previously described (20), but there (27) .
was still some residual lipoprotein lipase activity in the 5.2 P fraction. Even though lipase assays were carried out at pH 7.0, one might therefore anticipate some contribution from lipoprotein lipase if activator were added. As shown in Table IV , addition of serum or of the lipoprotein apoprotein activator, apoLp-Glu (26) , markedly enhanced triglyceride lipase activity. An attempt was made, then, to determine whether the cyclic AMP-dependent protein kinase system affected this lipoprotein lipase activity. As shown in Table IV , the addition of cyclic AMP and ATP-Mg' in the absence of a lipoprotein lipase activator enhanced lipolytic activity by 67%. Addition of either serum or apoLp-Glu increased basal lipase activity almost fourfold, the large increment presumably being due to lipoprotein lipase in the preparation. However, the incubation with cyclic AMP and ATP-Mgl* had little or no effect on this activity (i.e., there was no apparent deactivation). If anything, there was a slight increase in activity, the absolute magnitude of which was, within experimental error, the same as that seen in the absence of serum or apoLp-Glu. The results suggested that the hormone-sensitive lipase in the preparation was activated in the usual way but that lipoprotein lipase activity was unaffected by the cyclic AMP-dependent protein kinase system.
DISCUSSION
The results presented are compatible with the scheme for hormone-regulated activation of lipase shown in Fig. 7 . Previous studies established that hormone-receptor interaction leads to increased adenylate cyclase activity and the generation of higher levels of cyclic AMP, Sutherland and Rall's ubiquitous "second messenger" (28) . Our studies link second messenger generation to lipase activation through the action of a cyclic AMP-dependent protein kinase. Mediation of cyclic AMP action by way of protein kinase was first demonstrated by Walsh, Perkins, and Krebs in the activation of phosphorylase kinase (24) which then in turn activates phosphorylase, and by Larner and VillarPalasi in the conversion of glycogen synthase from the I to the D form (29) . The properties of protein kinase in human adipose tissue have not been elucidated, but in a variety of other tissues its activation has been shown to be effected by binding of cyclic AMP which causes dissociation of a receptor unit-catalytic unit complex (inactive in the absence of cyclic AMP), liberating the free catalytic unit (cyclic AMP-independent) (30) .
The specificity of the endogenous protein kinase with regard to cyclic nucleotide and nucleoside triphosphate cofactor requirements was similar to that of rabbit muscle and rat adipose tissue protein kinase. Corbin, Brostrom, Alexander, and Krebs have pointed out the general similarities of cyclic AMP-dependent protein kinases from different sources (31) . Quantitative comparisons are not too informative considering the limited purity of the systems studied, but it can be noted that lhalf-maximum rates of activation were obtained at about partially purified system. However, the fact that addition of protein kinase inhibitor during the activation process abruptly and completely arrested further activation rules against such a possibility (Fig. 6) .
Is the increase in lipolytic activity induced by hormones in intact adipose tissue effected by the activation system demonstrated in our cell-free extracts? If so, the lipase in homogenates prepared from tissue previously exposed to lipolytic hormones should already be largely in the activated form and consequently undergo little or no further activation by the cyclic AMP-dependent system. This was shown to be the case (Table  II) , strengthening the Fig. 7 , that the splitting of the first ester bond in triglycerides is rate limiting. The high basal activity of the lower glyceridases is evidently ample to maintain FFA and glycerol production at a rate determined by the fully-activated hormone-sensitive triglyceride lipase.
On the basis that reciprocal changes in lipoprotein lipase activity and hormone-sensitive lipase activity are observed in adipose tissue under certain conditions (hormonal stimulation of FFA mobilization, starvation, refeeding), it has been postulated that lipoprotein lipase activity might also be regulated via cyclic AMP, (i.e., it might be inactivated in the presence of elevated cyclic AMP levels) (27) . However Burns and Langley showed that in humiian fat (but liot in rat fat) epinephrine, in the presence of a /-adreliergic blocker (propranolol), reduces the rate of glycerol release well below basal values. The implication is that a-receptors mediate a decrease in lipase activity. In the context of the present results, this would imply that even in the basal state a significant fraction of the horimone-sensitive lipase is maintained in its activated form and that stimulation of a-receptors decreases cyclic AMP levels. However, the possibility that suppression of lipolytic activity in human fat by a-adrenergic agonists represents an alternative mechanism for control or expression of lipase activity cannot be ruled out.
